Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA

Por Kurup, Viswanath P, Knutsen, Alan P, Moss, Richard B, Bansal, Naveen K
Publicado em 2006

Effect of Media Modified To Mimic Cystic Fibrosis Sputum on the Susceptibility of Aspergillus fumigatus, and the Frequency of Resistance at One Center

Por Stevens, David A., Moss, Richard B., Hernandez, Cathy, Clemons, Karl V., Martinez, Marife
Publicado no Antimicrob Agents Chemother (2016)

Allergic Bronchopulmonary Aspergillosis

Por Tracy, Michael C., Okorie, Caroline U. A., Foley, Elizabeth A., Moss, Richard B.
Publicado no J Fungi (Basel) (2016)

The magnitude of ivacaftor effects on fluid secretion via R117H-CFTR channels: Human in vivo measurements

Por Char, Jessica E., Dunn, Colleen, Davies, Zoe, Milla, Carlos, Moss, Richard B., Wine, Jeffrey J.
Publicado no PLoS One (2017)

High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis

Por Tirouvanziam, Rabindra, Conrad, Carol K., Bottiglieri, Teodoro, Herzenberg, Leonore A., Moss, Richard B., Herzenberg, Leonard A.
Publicado em 2006

Fully Automated System for Three-Dimensional Bronchial Morphology Analysis Using Volumetric Multidetector Computed Tomography of the Chest

Por Venkatraman, Raman, Raman, Raghav, Raman, Bhargav, Moss, Richard B., Rubin, Geoffrey D., Mathers, Lawrence H., Robinson, Terry E.
Publicado em 2005

Efficacy and safety of ivacaftor treatment: randomized trial in subjects with cystic fibrosis who have an R117H-CFTR mutation

Por Moss, Richard B., Flume, Patrick A., Elborn, J. Stuart, Cooke, Jon, Rowe, Steven M., McColley, Susanna A., Rubenstein, Ronald C., Higgins, Mark
Publicado no Lancet Respir Med (2015)

Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways

Por Tirouvanziam, Rabindra, Gernez, Yael, Conrad, Carol K., Moss, Richard B., Schrijver, Iris, Dunn, Colleen E., Davies, Zoe A., Herzenberg, Leonore A., Herzenberg, Leonard A.
Publicado em 2008

Diagnostic Testing by CFTR Gene Mutation Analysis in a Large Group of Hispanics: Novel Mutations and Assessment of a Population-Specific Mutation Spectrum

Por Schrijver, Iris, Ramalingam, Sudha, Sankaran, Ramalingam, Swanson, Steve, Dunlop, Charles L.M., Keiles, Steven, Moss, Richard B., Oehlert, John, Gardner, Phyllis, Wassman, E. Robert, Kammesheidt, Anja
Publicado em 2005

Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs

Por Makam, Megha, Diaz, Daisy, Laval, Julie, Gernez, Yael, Conrad, Carol K., Dunn, Colleen E., Davies, Zoe A., Moss, Richard B., Herzenberg, Leonore A., Herzenberg, Leonard A., Tirouvanziam, Rabindra
Publicado em 2009

Inhibition of Aspergillus fumigatus and Its Biofilm by Pseudomonas aeruginosa Is Dependent on the Source, Phenotype and Growth Conditions of the Bacterium

Por Ferreira, Jose A. G., Penner, John C., Moss, Richard B., Haagensen, Janus A. J., Clemons, Karl V., Spormann, Alfred M., Nazik, Hasan, Cohen, Kevin, Banaei, Niaz, Carolino, Elisabete, Stevens, David A.
Publicado no PLoS One (2015)

A Little CFTR Goes a Long Way: CFTR-Dependent Sweat Secretion from G551D and R117H-5T Cystic Fibrosis Subjects Taking Ivacaftor

Por Char, Jessica E., Wolfe, Marlene H., Cho, Hyung-ju, Park, Il-Ho, Jeong, Jin Hyeok, Frisbee, Eric, Dunn, Colleen, Davies, Zoe, Milla, Carlos, Moss, Richard B., Thomas, Ewart A. C., Wine, Jeffrey J.
Publicado em 2014

Earth Mover’s Distance (EMD): A True Metric for Comparing Biomarker Expression Levels in Cell Populations

Por Orlova, Darya Y., Zimmerman, Noah, Meehan, Stephen, Meehan, Connor, Waters, Jeffrey, Ghosn, Eliver E. B., Filatenkov, Alexander, Kolyagin, Gleb A., Gernez, Yael, Tsuda, Shanel, Moore, Wayne, Moss, Richard B., Herzenberg, Leonore A., Walther, Guenther
Publicado no PLoS One (2016)

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation

Por Accurso, Frank J., Rowe, Steven M., Clancy, J.P., Boyle, Michael P., Dunitz, Jordan M., Durie, Peter R., Sagel, Scott D., Hornick, Douglas B., Konstan, Michael W., Donaldson, Scott H., Moss, Richard B., Pilewski, Joseph M., Rubenstein, Ronald C., Uluer, Ahmet Z., Aitken, Moira L., Freedman, Steven D., Rose, Lynn M., Mayer-Hamblett, Nicole, Dong, Qunming, Zha, Jiuhong, Stone, Anne J., Olson, Eric R., Ordoñez, Claudia L., Campbell, Preston W., Ashlock, Melissa A., Ramsey, Bonnie W.
Publicado em 2010

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

Por Clancy, JP, Rowe, Steven M, Accurso, Frank J, Aitken, Moira L, Amin, Raouf S, Ashlock, Melissa A, Ballmann, Manfred, Boyle, Michael P, Bronsveld, Inez, Campbell, Preston W, DeBoeck, Kris, Donaldson, Scott H, Dorkin, Henry L, Dunitz, Jordan M, Durie, Peter R, Jain, Manu, Leonard, Anissa, McCoy, Karen S, Moss, Richard B, Pilewski, Joseph M, Rosenbluth, Daniel B, Rubenstein, Ronald C, Schechter, Michael S, Botfield, Martyn, Ordoñez, Claudia L, Spencer-Green, George T, Vernillet, Laurent, Wisseh, Steve, Yen, Karl, Konstan, Michael W
Publicado em 2011